TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 184 filers reported holding TG THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.79 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $206,994 | -68.6% | 24,760 | -6.7% | 0.00% | -66.7% |
Q2 2023 | $659,303 | +69.2% | 26,542 | +2.4% | 0.00% | +50.0% |
Q1 2023 | $389,732 | +42.9% | 25,913 | +12.4% | 0.00% | +100.0% |
Q4 2022 | $272,788 | +102.1% | 23,059 | +0.8% | 0.00% | 0.0% |
Q3 2022 | $135,000 | +13400.0% | 22,865 | +8528.3% | 0.00% | – |
Q2 2022 | $1,000 | -75.0% | 265 | -35.7% | 0.00% | – |
Q1 2022 | $4,000 | +100.0% | 412 | +312.0% | 0.00% | – |
Q4 2021 | $2,000 | -50.0% | 100 | -9.9% | 0.00% | – |
Q3 2021 | $4,000 | -20.0% | 111 | -6.7% | 0.00% | – |
Q2 2021 | $5,000 | -16.7% | 119 | -4.8% | 0.00% | – |
Q1 2021 | $6,000 | -87.0% | 125 | -85.9% | 0.00% | -100.0% |
Q4 2020 | $46,000 | +84.0% | 885 | -5.3% | 0.00% | – |
Q3 2020 | $25,000 | +66.7% | 935 | +27.2% | 0.00% | – |
Q2 2020 | $15,000 | +400.0% | 735 | +22.5% | 0.00% | – |
Q3 2019 | $3,000 | -40.0% | 600 | 0.0% | 0.00% | – |
Q2 2019 | $5,000 | 0.0% | 600 | 0.0% | 0.00% | – |
Q1 2019 | $5,000 | – | 600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
Parkwood LLC | 165,414 | $6,081 | 0.66% |
Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |